Category: Infused Products & Extracts

Marijuana Company of America Launches New CBD Product hempSMARTâ„¢ Pain Cream

SHARE THIS POST Escondido, CA — (January 11, 2017) – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, through its wholly owned subsidiary hempSMART™, Inc., is pleased to announce the launch of hempSMART Pain Cream. Each bottle of HempSMART Pain Cream is formulated with 300mg of full spectrum non-psychoactive Cannabidiol (CBD) derived from industrial hemp. The newly developed product contains a synergistic combination of natural botanicals and full spectrum hemp extract featuring CBD, CBG and a broad range of terpenes. The Company’s proprietary blend of Ayurvedic herbs along with Menthol, Cayenne Pepper Extract, Rosemary Oil, Aloe Gel, White Willow Bark, Arnica, Wintergreen Extract and Tea Tree Oil, provides an immediate cooling and soothing sensation. This topical wellness product is formulated to help reduce minor discomfort, support normal joint mobility, and promote muscle relaxation on areas that it is applied. MCOA CEO Donald Steinberg commented, “We are excited to announce the expansion of our hempSMART personal care product line to include pain management products. We will continue to expand our health and wellness lines in 2018 to include more products. We expect that our Pain Cream will be enthusiastically received by our affiliates and customers.” About Marijuana Company of America, Inc. MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name...

Read More

Puration Plans Corporate Name Change in Conjunction With Extraction Spinoff and Dividend

SHARE THIS POST DALLAS, January 11, 2018 /PRNewswire/ — Puration, Inc. (PURA) today announced plans to change the company’s name in conjunction with the spinoff and dividend strategy announced last week. Management is rapidly advancing on a strategy to unlock shareholder value by dividing its cannabis infused beverage business and patented cannabis extraction business into two separately traded public companies. The first step in the strategy is to structure Puration’s extraction capacity into a new subsidiary. The next step will be to spinoff the cannabis extraction subsidiary in conjunction with a Regulation Crowdfunding transaction to capitalize the new independently listed company. The spinoff plan includes a dividend distribution of stock in the new independently listed company to shareholders of the parent company, Puration. Management plans to change the “Puration,” parent company name to reflect the cannabis infused beverage operations remaining in the parent company. Similarly, the subsidiary and spinoff company will be named to reflect the cannabis extraction operational focus. Extraction and Beverage Industry Experience  Puration is the sole licensee to U.S. Patent No. 9,199,960, entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.” The license permits Puration to produce cannabis extracts for infusion into recreational, fitness wellness, alternative medicine and beauty products. Management found the ideal first application of the extraction technology in the introduction of its own cannabis infused beverage. Last year, the company launched EVERx CBD Infused Sports Water which...

Read More

Neutrisci Announces Major Sponsorship with Tennis Star Genie Bouchard

SHARE THIS POST Vancouver, British Columbia – January 11, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis star Genie Bouchard, from Montreal, Quebec. NeutriSci is committed to encouraging active, healthy living and adds Bouchard to a growing list of amateur and professional athletes and ambassadors that represent neuenergy® globally. “Genie brings a passion for sport and healthy living. She is not only an amazingly talented tennis player but her down to earth attitude makes her the perfect representative; both men and women can relate to her,” said Glen Rehman, CEO of NeutriSci. “Her competitive nature and public profile embodies happiness, active and healthy living; and because of this, she is truly an inspiration to Canadians. We are proud to partner with such a strong Canadian athlete.” Bouchard has quickly made a name for herself due to her tremendous talent and drive. Genie has accumulated impressive accolades including being named the 2013 Women’s Tennis Association Newcomer of the Year and the 2013 Canadian Female Athlete of the Year. Genie’s historic 2014 season was highlighted by a WTA Top 5 debut, after reaching the semifinals of both the Australian Open and French Open, followed by a Wimbledon final appearance, making her the first Canadian, male...

Read More

Isodiol International Inc. Announces Letter of Intent to Import 99%+ Pure Pharma-Grade Cannabidiol to Canada from UK with Nuuvera

SHARE THIS POST January 11, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a letter of intent (LOI) with Nuuvera Holdings Limited (TSXV:NUU), a global cannabis company founded on Canadian principles, and built with the whole world in mind. Isodiol and Nuuvera have agreed to import 99%+ pure, bioactive pharma-grade cannabidiol (‘CBD’) isolate into Canada from Isodiol’s GMP-certified production facility in the United Kingdom.  The product, certified as a pharmaceutical-grade, will be imported into Canada through Nuuvera’s subsidiary, ARA – Avanti Rx Analytics Inc. (“Avanti”), a Health Canada GMP-certified laboratory holding a dealer license under the Narcotic Control Regulations and Office of Controlled Substances. “Since establishing Isodiol, we have focused on developing and marketing the highest quality, raw material for use in a range of proprietary, pharma grade nutritional and health related remedies,” said CEO of Isodiol, Marcos Agramont.  “We are very pleased that our new partner, Nuuvera, which brings to the table extensive knowledge and expertise in the fields of quality control, cannabis extraction, purification, product development and R&D, shares Isodiol’s vision for an industry built upon quality, consistency, safety, and ultimately, efficacy.  Isodiol and Nuuvera are at the global forefront of innovation in the cannabis industry,...

Read More

Creso launches JV Company with LGC Capital and Baltic Beer Company to capitalise on growing cannabis-derived beverages

SHARE THIS POST Highlights: Creso expands into the cannabis and hemp-derived beverage markets with the launch of CLV Frontier Brands Pty Ltd (“CLV”) which will develop and globally commercialise a bespoke portfolio of alcoholic and non-alcoholic beverages with cannabis and hemp ingredients. CLV is currently developing an initial premium four-beer range containing unique cannabis terpene mixes as well as other innovative ingredients. CLV will also create a vegan line for the consumer who demands this option. CLV is targeting shipping a first test batch of the initial beer range in April/May 2018, with commercial sales intended to commence in the third calendar quarter of 2018. CLV also intends to expand its product portfolio into other alcoholic and non-alcoholic beverages with various cannabis terpenes and other ingredients. First action under the JV will be to establish a pilot state-of-the-art R&D brewery facility in Tallinn, Estonia which will be dedicated to work on innovative recipes and to develop proprietary know-how and IP. CLV will have vast commercialisation reach spanning various continents leveraging the networks of all three companies. Creso Pharma Limited (ASX:CPH, the “Company” or “Creso”) is pleased to announce that it has formally launched its new joint venture company with LGC Capital Ltd (TSXV: LG) (“LGC”) and Baltic Beer Company Ltd (“Baltic Beer Company”) to capitalise on the fast-growing cannabis and hempderived beverage markets. The joint venture company – CLV...

Read More

Radient Technologies Inc. Provides Corporate Update and Announces Real Estate Expansion

SHARE THIS POST EDMONTON, ALBERTA and CALGARY, ALBERTA–(Marketwired – Jan. 9, 2018) – Radient Technologies Inc. (“Radient” or the “Corporation”) (TSX VENTURE:RTI) is pleased to provide the following update on its operations and 2018 growth initiatives. Real Estate Expansion As a part of these initiatives, Radient will be increasing its real estate footprint through a series of transactions. Radient has entered into a binding letter of intent (“LOI”) to acquire 100% interest in 1631807 Alberta Ltd., a joint venture company (the “JV”) between Radient and 1396730 Alberta Ltd. (owned by the Amnor Group) (the “Proposed Transaction”). The JV owns the land and building that contains the 20,000 square foot manufacturing facility in Edmonton, Canada (the “Facility”) operated by Radient. The Facility is approximately 20 kilometers from the Aurora Sky facility owned by Aurora Cannabis Inc. (“Aurora”) (TSX:ACB)(OTCQX:ACBFF)(FRANKFURT:21P)(WKN:A1C4WM). The Facility has a design capacity to process 5 metric tonnes/day of bio mass and has been operational since 2016. The Facility is fully GMP compliant with a pending ACMPR license expected to be issued by Health Canada later this year. Pursuant to the Proposed Transaction, RTI will be issuing 1,246,449 common shares, at a price of $1.40 (18% discount to the 10day VWAP), to 1396730 Alberta Ltd. as consideration for a 100% ownership in the JV. The Facility has an outstanding mortgage of $2.4 million held by BDC Canada. In addition, Radient expects to acquire...

Read More
  • 1
  • 2